Laura Byram is a visionary Biopharma leader with over 25 years of experience in the pharmaceutical industry. Currently serving as the Head of Mid Markets Europe at UCB, they manage the full product portfolio P&L for all ex-EU5 markets in Europe. Laura has held various pivotal roles including Global Head of Portfolio Strategy & Asset Optimization and Digital Health Solutions, Global Lead at UCB. They have completed executive education at INSEAD and are pursuing further studies in governance at IMD, while also dedicating efforts to building inclusive and empowered teams in the healthcare sector.
This person is not in any teams
This person is not in any offices